{"id":1706,"date":"2025-05-02T06:27:25","date_gmt":"2025-05-02T06:27:25","guid":{"rendered":"https:\/\/www.innoviusresearch.com\/blog\/?p=1706"},"modified":"2025-06-19T10:44:23","modified_gmt":"2025-06-19T10:44:23","slug":"the-rise-of-the-global-genome-editing-market","status":"publish","type":"post","link":"https:\/\/www.innoviusresearch.com\/blog\/market-report\/the-rise-of-the-global-genome-editing-market\/","title":{"rendered":"The Rise of the Global Genome Editing Market"},"content":{"rendered":"\n

Genome editing or gene editing <\/strong>is a genetic engineering technique that enables the modification of a single gene or a set of genes within the genome of an organism by altering the nucleotide sequence.<\/p>\n\n\n\n

The rapid evolution of CRISPR-based tools has significantly led to the market expansion, with applications across healthcare, agriculture, and biotech R&D.<\/strong><\/p>\n\n\n\n

Market Size and Forecast<\/strong><\/h5>\n\n\n\n

In 2024<\/strong>, the Global Genome Editing Market <\/strong>was valued at $9.64 billion <\/strong>and is expected to grow and reach to $24.58 billion <\/strong>by 2030<\/strong>.<\/p>\n\n\n\n

The global market is expected to grow at an approximate CAGR of 16.9% <\/strong>during the forecasted period 2024-2030.<\/p>\n\n\n\n

\"Global
Global Genome Editing Market During 2024-2030 ($Billion)<\/em><\/strong><\/figcaption><\/figure>\n\n\n\n

Advances in clinical gene therapies <\/strong>and growing applications in agriculture <\/strong>are accelerating the growth of the genome editing market.<\/p>\n\n\n\n

\"Global
Global Genome Editing Market Share, By Region 2024 (%)<\/em><\/strong><\/figcaption><\/figure>\n\n\n\n
Market Recent Trends<\/strong><\/h5>\n\n\n\n

Integration of AI<\/strong><\/p>\n\n\n\n

In 2025. AI tools <\/strong>have been instrumental in discovering small gene-editing proteins and predicting heat-tolerant RNA molecules, which have practical applications in therapy delivery and biomanufacturing.<\/p>\n\n\n\n

AI algorithms <\/strong>are increasingly being integrated into CRISPR-based<\/strong> gene editing to predict the most effective guide RNA\/DNA sequences, thereby improving editing precision and reducing off-target effects.<\/p>\n\n\n\n

Rapid Growth in Cell Line Engineering<\/strong><\/p>\n\n\n\n

The demand for engineered cell lines<\/strong> is propelled by their use in drug discovery, manufacturing, and the development of cell and gene therapies, with CRISPR accelerating the creation of isogenic cell models for research and validation.<\/p>\n\n\n\n

Cell line engineering is a booming application area, accounting for 55.1% <\/strong>of the genome editing market in 2025.<\/p>\n\n\n\n

Bridge RNA Technique<\/strong><\/p>\n\n\n\n

In 2024, Researchers at the Arc Institute have developed the “bridge RNA” <\/strong>method, a novel gene-editing technique that allows for precise genetic modifications without breaking DNA strands.<\/p>\n\n\n\n

This approach functions such as a “word processor” for the genome, enabling sequence-specific insertions and alterations.<\/p>\n\n\n\n

Increased Collaborations and Partnerships<\/strong><\/p>\n\n\n\n

The genome editing market is witnessing a surge in collaborations <\/strong>between industry players, academic institutions, and research organizations.<\/p>\n\n\n\n

For Example, In 2024, Danaher Corporation <\/strong>collaborated with the Innovative Genomics Institute (IGI) <\/strong>to develop CRISPR-based therapies for rare genetic disorders.<\/p>\n\n\n\n

In 2023, Cellectis<\/strong> and AstraZeneca<\/strong> entered into a collaboration agreement to accelerate advanced therapeutics development in oncology and immunology.<\/p>\n\n\n\n

Expansion of Genome Editing Applications<\/strong><\/p>\n\n\n\n

Beyond therapeutic applications, genome editing technologies, particularly CRISPR-based systems, are expanding into diagnostics<\/strong>.<\/p>\n\n\n\n

In Agriculture, AI-enhanced CRISPR techniques are being employed to develop gene-edited crops with improved traits. For example, an Australian trial is testing gene-edited wheat that aims to increase yields by 10%<\/strong>.<\/p>\n\n\n\n

Market End-Use Statistics<\/strong><\/h5>\n\n\n\n

In 2024, the largest segment in the End-use share of genome editing market was  Biotechnology & Pharmaceutical Companies <\/strong>at 60.2%<\/strong>, followed by Academic & Government Research Institutes at 24.6%, <\/strong>and Contract Research Organizations at 15.2%.<\/strong><\/p>\n\n\n\n

\"Genome
Genome Editing Market Share, By End-Use in 2024 (%)<\/em><\/strong><\/figcaption><\/figure>\n\n\n\n

The increasing use of personalized medicine <\/strong>and rising cases of genetic disorders <\/strong>and cancer are driving demand for precise genome editing tools in biotech and pharma.<\/p>\n\n\n\n

Market Delivery Method Insights<\/strong><\/h5>\n\n\n\n

In 2024, the Ex-vivo<\/strong> segment dominated the genome editing market, accounting for 63.7%<\/strong> of the total share; the In-vivo<\/strong> segment accounted for the remaining 36.3%<\/strong>. This growth was primarily driven by its expanding application in therapeutic areas.<\/p>\n\n\n\n

\"Genome
Genome Editing Market Share, By Delivery Type in 2024 (%)<\/em><\/strong><\/figcaption><\/figure>\n\n\n\n

The ex-vivo method is expected to see growing demand for personalized treatments<\/strong>, especially in cancer immunotherapy and rare genetic disorders, where cell-specific edits enhance treatment outcomes.<\/p>\n\n\n\n

Market Application Statistics<\/strong><\/h5>\n\n\n\n

In 2024, the largest segment in the Application share of genome editing market was  Cell Line Engineering (55.1%)<\/strong>, followed Animal Genetic Engineering (23.8%), Plant Genetic Engineering at (11.2%), <\/strong>and Others (9.9%).<\/strong><\/p>\n\n\n\n

\"Genome
Genome Editing Market Share, By Application in 2024 (%)<\/em><\/strong><\/figcaption><\/figure>\n\n\n\n

Advancements in editing technologies such as Zinc Finger Nucleases (ZFNs), CRISPR\/Cas, <\/strong>and TALENs<\/strong> have significantly reduced the cost and enhanced the efficiency of cell engineering processes.<\/p>\n\n\n\n

Market Technology Insights<\/strong><\/h5>\n\n\n\n

In 2024, the CRISPR\/Cas9 led the genome editing technology segment, accounting for 72.8, followed Animal Genetic Engineering (72.8%), Zinc Finger Nucleases (14.7%), TALENs (6.7%) <\/strong>and Others (5.8%).<\/strong><\/p>\n\n\n\n

\"Genome
Genome Editing Market Share, By Technology in 2024 (%)<\/em><\/strong><\/figcaption><\/figure>\n\n\n\n

The widespread use of CRISPR\/Cas9 can be attributed to its simplicity, affordability,<\/strong> and suitability<\/strong> for applications such as genetic disorder research and drug discovery.<\/p>\n\n\n\n

\n\n\n\n

Stay tuned to Innovius Research<\/strong> for ongoing market insights and data-driven analysis.<\/p>\n\n\n\n

Data Sources: Market.Us<\/a>, Nova One Advisor<\/a>, Roots Analysis<\/a>, Colossal Inc.<\/a>, Reuters<\/a>, Grand View Research<\/a>, The New Yorker<\/a> and others.<\/p>\n\n\n\n

Read more on Biotechnology<\/a><\/p>\n\n\n\n

Other Market Insights<\/strong><\/p>\n\n\n